Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: A randomized clinical trial

Hypertension in Pregnancy

Volumn 26, Issue 2, 2007, Pages 163-171

  Gracia, Paulino Vigil De ^a,b   Ruiz, Esteban ^a   López, Juan C ^a   De Jaramillo, Ilka Alveo ^a   Vega Maleck, Juan C ^a   Pinzón, Jaime ^a  

^a Obstetric Intensive Unit   (Panama)

^b NONE   (Panama)

Author keywords

Hydralazine; Labetalol; Postpartum; Preeclampsia; Severe hypertension

Indexed keywords

HYDRALAZINE; LABETALOL;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD PRESSURE REGULATION; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ECLAMPSIA; EPIGASTRIC PAIN; FEMALE; FLUSHING; HEADACHE; HEART PALPITATION; HELLP SYNDROME; HUMAN; HYPERTENSION ENCEPHALOPATHY; HYPOTENSION; LUNG EDEMA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; NAUSEA; OLIGURIA; POSTPARTUM HYPERTENSION; PUERPERIUM; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TACHYCARDIA; TREATMENT OUTCOME; VISUAL FIELD DEFECT; VOMITING;

ADULT; ANALYSIS OF VARIANCE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYDRALAZINE; HYPERTENSION, PREGNANCY-INDUCED; INFUSIONS, INTRAVENOUS; LABETALOL; PANAMA; POSTPARTUM PERIOD; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34247603953     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950701204430     Document Type: Article

References (14)

1. ACOG. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No. 33 American College of Obstetricians and Gynaecologists. Obstet Gynecol 2002; 99:159-167.
2. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 1992; 99:547-553.
3. Walters BNJ, Thompson ME, Lee A, de Swiet M. Blood pressure in the pueperium. Clin Sci 1986; 71:589-594.
4. Lewis G. Why mothers die. Report on confidential inquiries into maternal deaths in the United Kingdom 1997-99. London: RCOG Press, 2001.
5. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000; 183:S1-S22.
6. Rey E, LeLorier J, Burgess E, Lange IR, Leduc L. Report of the Canadian Hypertension Society Consensus Conference:3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 1997; 157:1245-1254.
7. Martin JN, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105:246-254.
8. Mabie WC, Gonzalez AR, Sibai BM, Amon E. A comparative trail of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 1987; 70:328-333.
9. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003; 102:181-192.
10. Cunningham FG, Gant NF, Leveno KJ, et al. Hypertensive disorders in Pregnancy, In Williams Obstetrics, 21st ed. New York, McGraw-Hill health professions Division, 2001; pp 567-618.
11. Duley L, Henderson-Smart DJ. Drugs for rapid treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2003; 2.
12. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003; 327:955-960.
13. Magee L, Sadeghi S. Prevention and treatment of postpartum hypertension (Cochrane Review). In: The Cochrane Library, Issue 1, 2005. Oxford: Update Software.
14. Bolte AC, van Geijn HP, Dekker GA. Management and monitoring of severe preeclampsia. Eur J Obstet Gynecol Rep Biol 2001; 96:8-20.